WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its weight-management programs, sending its shares up 13% in early trading. Soaring demand for weight-loss drugs such as Wegovy and Eli Lilly's Zepbound,
WeightWatchers to offer compounded GLP-1 weight-loss drugs
WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide
WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its WeightWatchers Clinic members, expanding the accessibility of popular weight loss medications to its members at a more affordable price.
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight management interventions that are underpinned by the comprehensive,
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
Shares of WW International Inc., known as WeightWatchers, soared 18% Tuesday, after the weight-management company announced the addition of compounded GLP-1 obesity treatments to its offering. The new offering starts at $129.
Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.
WeightWatchers is getting in on the off-brand weight loss drug game — and selling them cheap
WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in the industry.
The Holy Mess on MSN8d
New Updates! Weight Watchers Changes for 2024
What’s going on with Weight Watchers? With the CEO stepping down, a new body-positive approach, continual app changes, ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
Tara Comonte, a WeightWatchers board member and former Shake Shack executive, was made interim chief executive. The New ...
The Root9d
A Look at Oprah's Complicated, Inspiring Weight Loss Journey Over the Years
The media mogul has oft been the go-to girl for weight loss inspiration, tips, and tricks for years. So let's take a look at ...
UPI13d
WW International removes CEO
Sept. 28 (UPI) --WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously known as Weight Watchers said in a statement. Sistani ...
Ticker: WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
Cook Eat Go on MSN2d
3 Ingredient Strawberry Weight Watcher Muffins!
Weight Watchers Strawberry Muffins are the perfect light treat to make at home! I am a huge fan of baking, and the easie ...